Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

Featured Articles | Featured Partners | Videos | Industry News | Events

December 16, 2025

Newsletter Sponsor

Enabling Technologies for Poorly Soluble Molecules
Targeted protein degraders (TPDs) are an emerging modality, with exponential growth likely in the coming years. However, their complex molecular structure leads to poor solubility and bioavailability.

To combat this, PCI has formed a network of industry-leading drug development experts to provide a suite of enabling technologies to our clients. With deep expertise in micronization, spray drying, hot melt extrusion and nanomilling, our clients receive a product-first, platform-agnostic solution for their drug product.

	Industry News

	Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials Lindus Health and Quotient Sciences announced a strategic partnership to enable innovative biotech ... read more »

	CluePoints Wins 2025 Scrip Award CluePoints has won the ‘Best Contract Research Organization– Specialist Providers’ category at the ... read more »

	Gaelic Labs Acquires Athlone Labs Gaelic Laboratories announced its acquisition of Athlone Laboratories, a developer and manufacturer ... read more »

	Piramal Pharma Achieves Outstanding Net Promoter Score Piramal Pharma Solutions has achieved a Net Promoter Score (NPS) of 55 for the time period ... read more »

	Featured Articles

		Executive Q&A - Early Drug Development In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during ... read more »

		Beyond Wearables: How Integrated BGM + eCOA Solutions are Solving Real World Problems in Obesity Clinical Research In today’s highly connected healthcare ecosystem, wearable technology and electronic Clinical Outcome Assessments (eCOA) are converging to create new and unique opportunities for patient empowerment ... read more »

	Featured Video

Kindeva's Purpose-Built Aseptic Fill/Finish Facility in Bridgeton, MO
Kindeva's Purpose-Built Aseptic Fill/Finish Facility in Bridgeton, MO read more »

Cell & Gene Therapy: Advancing the Next Generation of Pharmaceuticals
In this documentary, American Pharmaceutical Review and Pharmaceutical Outsourcing magazine spoke with industry experts to learn how cell and gene therapies are changing the healthcare landscape and ... read more »

	More Services

Expression Technologies Learn More
Advanced Chemical, Microbiological & Stability Testing Learn More
Pre-Formulation Services Learn More

	Service Directory

Contract Pharmaceutical Formulation Development Services by Dosage Form Search More

Recombinant Protein Bioprocess Services Search More

	Events

KENX Webinar: Validation Documentation: Avoiding Common Mistakes That Lead to Delays
Virtual – 12/17/2025
Join us for an insightful webcast focusing on the intricacies of validation documentation within the pharmaceutical and biotech industries. This ... event details »

KENX Webinar: AI in GxP: What’s Next for 2026?
Virtual – 01/21/2026
Join us for an insightful webcast exploring the evolving role of Artificial Intelligence (AI) in Good Practice (GxP) environments as we approach 2026.... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA